What is the price target for INAB stock?
10 analysts have analysed INAB and the average price target is 50.75 USD. This implies a price increase of 2363.35% is expected in the next year compared to the current price of 2.06.
IN8BIO INC (INAB) Forecast, Price Target & Analyst Ratings
NASDAQ:INAB • US45674E2081
Current stock price
2.06 USD
+0.17 (+8.99%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IN8BIO INC (INAB).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 1, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.63
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$50.75
Upside
+ 2,363.35%
From current price of $2.06 to mean target of $50.75, Based on 10 analyst forecasts
Low
$4.04
Median
$7.65
High
$189.00
Price Target Revisions
1 Month
1.02%
3 Months
1.02%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for INAB. The average price target is 50.75 USD. This implies a price increase of 2363.35% is expected in the next year compared to the current price of 2.06.
The average price target has been revised upward by 1.02% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.00%
INAB was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about INAB.
In the previous month the buy percentage consensus was at a similar level.
INAB was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | Jones Trading | Upgrade | Hold -> Buy |
| 2024-11-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-12 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-06-14 | Jones Trading | Maintains | Buy -> Buy |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-18 | Laidlaw & Co. | Initiate | Buy |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-13 | JonesTrading | Initiate | Buy |
| 2023-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-05 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-24 | Mizuho | Reiterate | Buy |
| 2023-04-17 | EF Hutton | Maintains | Buy |
| 2023-03-31 | EF Hutton | Reiterate | Buy |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-29 | EF Hutton | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 1, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.63
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 47.58%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
32.97%
Next Earnings Summary
INAB is expected to report earnings on 5/1/2026. The consensus EPS estimate for the next earnings is -0.63 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 3,064.31% | N/A 14.17% | N/A 87.92% | N/A 57.86% | N/A 26.33% | N/A 37.18% | ||||||||
| EBITDA YoY % growth | -1.9M | -4.96M -161.05% | -8.47M -70.77% | -14.02M -65.53% | -27.91M -99.07% | -28.504M -2.13% | -27.764M 2.60% | N/A 44.89% | N/A -73.33% | N/A -80.77% | N/A 29.79% | N/A -15.15% | N/A 76.32% | N/A 288.89% | N/A 141.18% | N/A | |
| EBIT YoY % growth | -2M | -5.06M -153.00% | -8.56M -69.17% | -14.65M -71.14% | -28.52M -94.68% | -30.337M -6.37% | -29.599M 2.43% | N/A 67.39% | N/A -110.64% | N/A -24.79% | N/A 80.70% | N/A -435.29% | N/A 75.61% | N/A 343.76% | N/A 98.00% | N/A 36.88% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -42.60 10.76% | -30.30 28.87% | -17.40 42.57% | N/A 73.62% | N/A 61.78% | N/A -12.79% | N/A 240.89% | N/A -158.72% | N/A 58.57% | N/A 132.33% | N/A 246.51% | N/A 86.58% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.63 47.58% | -0.33 84.46% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -3.912M 37.15% | -4.182M 26.11% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
23.56%
EPS Next 5 Year
13.77%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-17.46%
EBIT Next 5 Year
-5.55%
IN8BIO INC / INAB Forecast FAQ
Can you provide the upcoming earnings date for IN8BIO INC?
IN8BIO INC (INAB) will report earnings on 2026-05-01.
What are the consensus estimates for INAB stock next earnings?
The consensus EPS estimate for the next earnings of IN8BIO INC (INAB) is -0.63 USD and the consensus revenue estimate is 0 USD.
What is the number of analysts for INAB stock?
The number of analysts covering IN8BIO INC (INAB) is 10.